Rabies Diagnostics Market Scenario
Global Rabies Diagnostics Market Growth is accounted for USD 1964 Million in 2017 and expected to register 4.36% CAGR during the forecast period (2018–2023).
Rabies is a deadly disease caused by biting of an infected rabid animal which can affect both human and animal health. Patient suffering from rabies is likely to experience fever, headache, muscle aches, loss of appetite, nausea, and tiredness.
The increasing prevalence of rabies, raising awareness related to rabies, and the increasing number of animals are expected to drive the growth of the global rabies diagnostics market during the forecast period. Moreover, rising research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. For instance, in May 2016, the Centers for Disease Control and Prevention(CDC) developed LN34 innovative rapid rabies test for early detection of rabies.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7796
However, high costs associated with the diagnostic, and rising vaccination may hamper the growth of the market during the assessment period.
Rabies Diagnostics Market Segmentation
The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region.
On the basis of method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests. Also, by technology, the market has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others.
Based on market has been divided into hospitals, diagnostic centers, cancer palliative care clinics, and others. By end-user hospitals are likely to register the highest CAGR owing to the rising prevalence of rabies in emerging countries during the forecast period.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rabies diagnostics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European rabies diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The rabies diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rabies diagnostics market in the Middle East & Africa has been segmented into the Middle East and Africa.
Rabies Diagnostics Regional Market Summary
Asia-Pacific is likely to dominate the rabies diagnostics market during the forecast period owing to the improving healthcare infrastructure, rising investments in healthcare and expansions by market players in the region. Also, countries such as India and China are considering the fastest growing region due to a government focused toward adopting new technology and the best treatment option from a developed country. According to the World Health Organization, in 2010, the healthcare expenditure of India was 3.27% of GDP, whereas, in 2015 it has 3.89% of total GDP.
The Americas are likely to be the second-largest market in the global rabies diagnostics market owing to the rising strategic alliance by major players, increasing awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure. According to the American Pet Products Association’s 2017-2018 National Pet Owners Survey, Number of animals in the American region is increasing, and there were around 60.2 million dogs, and 47.1 pet cats were present in the Americas.
The European market is expected to hold a significant share in the rabies diagnostics market. The market growth in this region can be attributed to the government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development.
The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
RABIES DIAGNOSTICS MARKET KEY PLAYERS
SOME OF THE KEY PLAYERS IN THE GLOBAL RABIES DIAGNOSTICS MARKET ARE BIO-RAD LABORATORIES, INC., MERCK KGAA, AVIVA SYSTEMS BIOLOGY CORPORATION, CREATIVE DIAGNOSTICS, DEMEDITEC DIAGNOSTICS GMBH, ABBEXA LTD., NORGEN BIOTEK CORP., BIONOTE, INC., EXPRESS BIOTECH INTERNATIONAL INC., MYBIOSOURCE.COM., AND BIOGEN TECHNOLOGIES
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796
No comments:
Post a Comment